Global Viral Detection Market Growth (Status and Outlook) 2025-2031

Global Viral Detection Market Growth (Status and Outlook) 2025-2031

The global Viral Detection market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

United States market for Viral Detection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Viral Detection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Viral Detection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Viral Detection players cover Avance Biosciences Inc (US), BSL BIOSERVICE (Germany), Clean Cells (France), Charles River Laboratories International, Inc (US), Lonza Group (Switzerland), etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Viral Detection Industry Forecast” looks at past sales and reviews total world Viral Detection sales in 2024, providing a comprehensive analysis by region and market sector of projected Viral Detection sales for 2025 through 2031. With Viral Detection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Viral Detection industry.

This Insight Report provides a comprehensive analysis of the global Viral Detection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Viral Detection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Viral Detection market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Viral Detection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Viral Detection.

This report presents a comprehensive overview, market shares, and growth opportunities of Viral Detection market by product type, application, key players and key regions and countries.

Segmentation by Type:
Plaque Assays
PCR
ELISA
Others

Segmentation by Application:
Blood & Blood Products
Cellular & Gene Therapy Products
Stem Cell Products
Tissue & Tissue Products
Vaccines and Therapeutics

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Avance Biosciences Inc (US)
BSL BIOSERVICE (Germany)
Clean Cells (France)
Charles River Laboratories International, Inc (US)
Lonza Group (Switzerland)
Merck KGaA (Germany)
Sigma-Aldrich Corporation (US)
SGS S.A. (Switzerland)
Texcell, Inc. (France)
WuXi PharmaTech (Cayman) Inc. (China)

Please note: The report will take approximately 2 business days to prepare and deliver.